RGNX — Regenxbio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Regenxbio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	296	476	457	365	275
Net Total Accounts Receivable
Net Total Receivables	38.1	43	32.4	28.1	24.8
Prepaid Expenses
Total Other Current Assets
Total Current Assets	345	531	519	416	335
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	39.1	120	192	207	193
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	498	708	1,114	833	574
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	33.7	81.4	130	130	130
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	47.7	330	350	317	262
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	450	378	764	516	312
Total Liabilities & Shareholders' Equity	498	708	1,114	833	574
Total Common Shares Outstanding